These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22941191)

  • 41. Oncogenic mutations of ALK kinase in neuroblastoma.
    Chen Y; Takita J; Choi YL; Kato M; Ohira M; Sanada M; Wang L; Soda M; Kikuchi A; Igarashi T; Nakagawara A; Hayashi Y; Mano H; Ogawa S
    Nature; 2008 Oct; 455(7215):971-4. PubMed ID: 18923524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
    Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
    Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
    Guo Y; Chen Y; Ito H; Watanabe A; Ge X; Kodama T; Aburatani H
    Gene; 2006 Dec; 384():51-61. PubMed ID: 16971064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.
    Helland Å; Anglesio MS; George J; Cowin PA; Johnstone CN; House CM; Sheppard KE; Etemadmoghadam D; Melnyk N; Rustgi AK; Phillips WA; Johnsen H; Holm R; Kristensen GB; Birrer MJ; ; Pearson RB; Børresen-Dale AL; Huntsman DG; deFazio A; Creighton CJ; Smyth GK; Bowtell DD
    PLoS One; 2011 Apr; 6(4):e18064. PubMed ID: 21533284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
    Hungate EA; Applebaum MA; Skol AD; Vaksman Z; Diamond M; McDaniel L; Volchenboum SL; Stranger BE; Maris JM; Diskin SJ; Onel K; Cohn SL
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study.
    Hua RX; Zhuo Z; Ge L; Zhu J; Yuan L; Chen C; Liu J; Cheng J; Zhou H; Zhang J; Xia H; Zhang X; He J
    J Cell Mol Med; 2020 Jan; 24(1):1059-1066. PubMed ID: 31747721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
    Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
    J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.
    Xue C; Yu DM; Gherardi S; Koach J; Milazzo G; Gamble L; Liu B; Valli E; Russell AJ; London WB; Liu T; Cheung BB; Marshall GM; Perini G; Haber M; Norris MD
    Oncotarget; 2016 Aug; 7(34):54937-54951. PubMed ID: 27448979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
    Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
    J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
    Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
    Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitination of IGF2BP3 by E3 ligase MKRN2 regulates the proliferation and migration of human neuroblastoma SHSY5Y cells.
    Jia C; Tang H; Yang Y; Yuan S; Han T; Fang M; Huang S; Hu R; Li C; Geng W
    Biochem Biophys Res Commun; 2020 Aug; 529(1):43-50. PubMed ID: 32560817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
    Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
    J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma.
    Yu M; Ohira M; Li Y; Niizuma H; Oo ML; Zhu Y; Ozaki T; Isogai E; Nakamura Y; Koda T; Oba S; Yu B; Nakagawara A
    Int J Oncol; 2009 Apr; 34(4):931-8. PubMed ID: 19287950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
    Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B.
    Vishnubalaji R; Elango R; Al-Toub M; Manikandan M; Al-Rikabi A; Harkness L; Ditzel N; Atteya M; Hamam R; Alfayez M; Aldahmash A; Kassem M; Alajez NM
    Sci Rep; 2019 May; 9(1):8101. PubMed ID: 31147574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HACE1 is a potential tumor suppressor in osteosarcoma.
    El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
    Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.
    Cotterman R; Knoepfler PS
    PLoS One; 2009 Jun; 4(6):e5799. PubMed ID: 19495417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic susceptibility to neuroblastoma.
    Tolbert VP; Coggins GE; Maris JM
    Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
    Volchenboum SL; Li C; Li S; Attiyeh EF; Reynolds CP; Maris JM; Look AT; George RE
    Cancer Res; 2009 May; 69(10):4143-9. PubMed ID: 19435921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.